Altheogen's ESG Excellence Recognized by EcoVadis
Altheogen (196170) has achieved remarkable success in the 2026 EcoVadis ESG assessment, ranking among the top 4% of participating companies globally and securing the prestigious "Gold" medal. This accomplishment comes just a year after their initial Bronze medal achievement, showcasing a rapid ascent in sustainability performance.
The company's commitment to environmental stewardship, labor rights, ethics, and sustainable procurement has been recognized across all four key areas, with scores ranging from 83 to 85. EcoVadis medals are awarded based on performance, with Platinum reserved for the top 1%, Gold for the top 5%, Silver for the top 15%, and Bronze for the top 35%.
With over 150,000 companies from 180 countries participating in the assessment, Altheogen's achievement is a testament to their dedication to sustainable practices and their ability to meet global ESG standards. This recognition is particularly significant as it aligns with the company's efforts to enhance its sustainability profile and attract global pharmaceutical partners and investors.
Altheogen's journey towards sustainability excellence is a testament to their strategic vision and commitment to creating long-term value for all stakeholders. As the company continues to innovate and grow, its ESG performance will undoubtedly remain a key differentiator and a source of competitive advantage.
Altheogen Receives Top Marks for Carbon Rating and ESG Initiatives
The company has achieved the 'Advanced' rating in the Carbon Rating assessment, which specifically evaluates its climate change response capabilities. Altheogen has demonstrated its commitment to managing greenhouse gas emissions and implementing decarbonization policies, reduction activities, and external disclosure and reporting practices.
EcoVadis, headquartered in France, is a leading supply chain sustainability assessment agency with over 150,000 companies across 180 countries participating. It verifies corporate ESG policies, activities, and performance against international standards. The evaluation results are utilized by global pharmaceutical companies to assess and maintain their supply chains when selecting partners and awarding contracts. Additionally, investors leverage these assessments for their own ESG evaluations.
Altheogen has declared this year as the "ESG Management Inaugural Year," restructuring its organizational and management systems accordingly. The company has established an ESG Committee within its board of directors and formed a dedicated ESG team comprising specialized professionals.
Altheogen's Commitment to Sustainability and Environmental Leadership
The company has made significant strides in its environmental initiatives, solidifying its position as a leader in the chemical research and development industry. Altheogen has established a third-party verified greenhouse gas inventory, achieving the CDP Management Level and gaining approval for its short-term greenhouse gas reduction targets from SBTi. This milestone is a first for the KOSDAQ biotech sector, according to the company.
Furthermore, Altheogen has actively engaged in activities related to the United Nations Sustainable Development Goals (SDGs), the United Nations Global Compact (UNGC), and the Korean version of RE100 (K-RE100). The company has also embarked on a transition to renewable energy, acquiring ISO 14001 certification for environmental management and ISO 45001 for occupational health and safety. These achievements complement Altheogen's sustainable management framework, as evidenced by the publication of its first sustainability report.
"When considering our performance in the chemical R&D sector, our company ranks among the top 2% of global enterprises that have undergone EcoVadis assessments over the past 12 months," explained Tae-yeon Jeon, CEO of Altheogen.
Jeon further stated, "The attainment of the EcoVadis Gold Medal signifies more than just a positive evaluation; it demonstrates our capability to earn the trust of global pharmaceutical partners and investors through our sustainable management practices. We will not rest on our laurels and are committed to continuous improvement across all aspects of our management system, encompassing environmental, labor and human rights, ethical, and sustainable procurement domains."
Altheogen's dedication to sustainability and its efforts to reduce its environmental impact position it as a responsible corporate citizen, attracting attention from global investors and partners seeking environmentally conscious collaborations.
